Chemotherapy Usually Intended for Dogs is Treating a Red Fox’s Lymphoma

Purdue Veterinary Hospital and Wolf Park Collaborate to Treat an Unusual Patient

Chris sits beside Joker the fox holding out his hand as Joker stands on a log looking up at him
The most rewarding part of Joker’s treatment, for Dr. Chris Fulkerson, has been seeing his tumors responding and watching him live his life as normal. (Purdue University photo/John Underwood)

The Purdue University Veterinary Hospital works with many patients across species. None are more unusual perhaps than Joker, an eight-year-old silver-phased red fox undergoing treatment for lymphoma. Joker resides at Wolf Park, a nonprofit conservation facility located in nearby Battle Ground, Ind.

During a routine medical check in November, his handler, Kimber Hendrix, noticed small tumors on his tongue.  Wolf Park’s veterinarian, Dr. Julia Becker, sent a biopsy to the Animal Disease Diagnostic Laboratory at the Purdue University College of Veterinary Medicine, where Joker was diagnosed with T-cell lymphoma by Dr. Mario Sola, assistant professor of diagnostic pathology.  Dr. Becker then referred Joker’s case to Dr. Christopher Fulkerson, clinical assistant professor of veterinary medical oncology in the College of Veterinary Medicine. 

Dr. Fulkerson hadn’t previously worked with a fox patient. He and his team couldn’t find any literature about this type of lymphoma in foxes, so they are treating Joker based on a protocol often used for dogs with lymphoma. This chemotherapy protocol mainly uses chemotherapy pills, which the team thought was most likely to be well-tolerated and successful.

According to Dr. Fulkerson, Joker’s behavior is similar to that of a dog. He is as wild as possible at Wolf Park, but is social and trained for medical procedures. “He’s a really laid-back fox,” Hendrix said. “He’s a sweet guy to work with. He’s a great animal ambassador.”

Joker has been at Wolf Park since 2015, when he was rescued after being found under a porch. His laid back personality – accompanied with a knack of playing practical jokes on his den mate Scarlette – make him a favorite among visitors.

Chris wears a mask outside at Wolf Park as he holds out an egg that Joker the fox puts in his mouth
After a treatment at Wolf Park, Dr. Chris Fulkerson rewards Joker with his favorite treat: an egg. (Purdue University photo/John Underwood)

To minimize his stress and anxiety, as many procedures as possible are followed at Wolf Park. Since January, Dr. Fulkerson has been going to Wolf Park almost weekly to administer Joker’s treatment and check his laboratory reports. On these days, Joker is rewarded with a special treat: an egg.

Joker is responding well to chemotherapy. After a few weeks of treatment, his lymphoma is in partial remission, meaning most of the lesions have gone away or have substantially decreased in size. He is undergoing chemotherapy treatments until mid-April. The hope is that over time, complete remission is achieved with the disappearance of all lesions, although the treatment time frame may be extended if lesions remain.

“We follow his lab work really closely to make sure that the chemotherapy drugs aren’t having any adverse effects on his white blood cell count. This drug can also cause liver injury, so we monitor his liver function and liver values. That all has been good throughout all the treatment, with no signs of obvious chemotherapy side effects,” Dr. Fulkerson said.

In captivity, red foxes can live 12-14 years. Each day, Joker engages in training and enrichment with staff and volunteers, and he has plenty of energy to play with his enrichment objects. Hendrix said that even during treatment, he hasn’t had any bad days.

Dr. Fulkerson said that the most gratifying and exciting part of Joker’s treatment has been seeing his tumors responding and seeing him living his life as normal.

“I was wearing my mask because of COVID-19,” he said of a recent visit, “But I told his handlers if they could have seen my face under it, I probably had one of the biggest smiles I’d had in the last year just from seeing him frolicking around and being excited and happy.”

Dr. Fulkerson treats Joker the fox as his handler holds him on an exam table in the Purdue University Veterinary Hospital
Dr. Chris Fulkerson, clinical assistant professor of veterinary medical oncology, treats Joker, a silver-phased red fox, at the Purdue University Veterinary Hospital. (Purdue University photo/John Underwood)

Purdue has offset the cost of some of Joker’s procedures with teaching funds. Joker’s lymphoma already has been a good learning case for diagnostic imaging, oncology, and pathology.  Following Joker’s progress may help with treatment of similar cases in the future.

The remaining costs, as of now, have been fully funded through donations to Wolf Park, although more need may arise in the future if his treatment is extended.

Hendrix said she’s thankful that Wolf Park has been able to partner with Purdue on Joker’s treatment.

“I just really have loved the partnership that has blossomed between Wolf Park and Purdue throughout this,” she said. “I’d love for there to be something that comes out of this to help other exotics so that people learn more about the progression of the disease, can help other animals in human care and can do more for them. Anything that can be learned from his case would be wonderful.”

Dr. Fulkerson agrees. He and his team plan to compile a case report on Joker so that this treatment option is documented to help other foxes diagnosed with lymphoma in the future.

“One of the great things about being at Purdue and being an academic veterinarian is that we can see some of these unusual things, we have some resources we can bring to help us learn about them, and then we can share that information with other veterinarians to help other patients in the future,” he said.

Click here to view a full Purdue news release.

Writer(s): Kelsey Lefever, Purdue Marketing and Communications | pvmnews@purdue.edu

Recent Stories

“Paws Up” – brought to you by the PVM Wellness Committee

Behind the scenes, Alicia Williams has been making PVM a kinder, stronger place.

Purdue Veterinary Medicine Computational Biologist Uses Big Data, AI and Math to Find Patterns in Cancer

With recent advances, cancer research now generates vast amounts of information. The data could help researchers detect patterns in cancer cells and stop their growth, but the sheer volume is just too much for the human mind to digest. Enter Nadia Lanman, research associate professor in the Department of Comparative Pathobiology, whose expertise in computational biology helps researchers at Purdue University distill solutions from the sea of numbers.

Purdue to Host Fourth Annual Antimicrobial Conference in February

With leadership by the Purdue University College of Veterinary Medicine, the Fourth Annual Conference on Antimicrobial Resistance (AMR) will be held at Purdue University West Lafayette February 25–26, 2026. With multidrug-resistant infections on the rise globally, this event brings together experts and practitioners across the spectrum of human, animal, and environmental health to address one of today’s most urgent public health challenges.

PVM Well-represented by Humans and Animals During Annual Homecoming Celebrations

Every fall, Boilermakers from near and far return to the campus in West Lafayette for the annual ritual known as Homecoming. And Purdue’s Homecoming events also attract plenty of non-alumni who are Purdue fans, patrons, prospective students, or clients of the Purdue University Veterinary Hospital. During this year’s Homecoming weekend October 24-25, Purdue Veterinary Medicine engaged with attendees in multiple ways, with the help of some furry companions.

Purdue University and Akston Biosciences Bring “First Dose of Hope” in New Cancer Immunotherapy Trial for Dogs with Urinary Bladder Cancer

The Purdue University College of Veterinary Medicine, in partnership with Akston Biosciences Corporation, has initiated the enrollment of dogs with urinary bladder cancer in a clinical trial of a pioneering immunotherapy. The strategic partnership between Purdue and Akston was announced in August after the underlying technology was developed at the College of Veterinary Medicine and the Purdue Institute for Cancer Research (PICR).

“Paws Up” – brought to you by the PVM Wellness Committee

Today we share appreciation for Beth Laffoon, MS, RVT, and Holly McCalip, BS, RVT, who are both instructional technologists in the Veterinary Nursing Program.

MMAS Symposium Brings Participants Face to Face with Specialists and Species from Parrots to Pocket Pets

Thanks to Purdue Veterinary Medicine’s Exotic Animal Club and dedicated faculty, staff and students, nearly 100 in-person and on-line participants got a chance recently to gain valuable knowledge and insight about the Medicine of Mammalian and Avian Species. The two-day educational event known as the MMAS Symposium is a biennial conference, and the 2024 edition held in Lynn Hall November 9 and 10 featured an impressive program that included 22 lectures and several hands-on labs, organized into two tracks focusing on avian and mammalian species.

Veterinary Boilermakers Take Part in Purdue One Health Alumni Reunion

Purdue University College of Veterinary Medicine faculty, staff and students turned out for Purdue University’s first One Health Alumni Reunion, which was held on the West Lafayette campus November 14-16. They joined more than 150 Boilermakers from a variety of medical professions who came together to network and participate in timely discussions with Purdue President Mung Chiang, First Lady Kei Hui and fellow alumni.